| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 102.86B | 105.88B | 92.11B | 89.12B | 92.65B | 89.63B |
| Gross Profit | 18.00B | 18.38B | 16.13B | 13.99B | 14.62B | 14.08B |
| EBITDA | 9.53B | 9.92B | 9.34B | 8.12B | 8.00B | 7.51B |
| Net Income | 5.01B | 5.17B | 4.57B | 3.76B | 3.78B | 3.65B |
Balance Sheet | ||||||
| Total Assets | 90.58B | 99.63B | 103.20B | 97.07B | 96.52B | 100.23B |
| Cash, Cash Equivalents and Short-Term Investments | 15.59B | 16.96B | 23.06B | 20.60B | 20.12B | 14.07B |
| Total Debt | 6.16B | 8.46B | 10.05B | 11.48B | 13.01B | 14.09B |
| Total Liabilities | 26.22B | 34.74B | 41.41B | 41.16B | 42.34B | 48.66B |
| Stockholders Equity | 64.27B | 64.81B | 61.74B | 55.85B | 54.12B | 51.53B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.02B | 4.62B | 2.45B | 8.51B | 8.11B |
| Operating Cash Flow | 0.00 | -536.00M | 6.04B | 3.81B | 9.92B | 9.42B |
| Investing Cash Flow | 0.00 | -1.18B | -598.00M | 148.00M | -1.59B | -1.75B |
| Financing Cash Flow | 0.00 | -4.28B | -3.11B | -3.13B | -2.55B | -2.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥92.60B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
76 Outperform | ¥257.66B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
72 Outperform | ¥1.23T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥675.51B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
70 Outperform | ¥539.65B | 14.38 | ― | 2.51% | 15.47% | 64.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |